Tara Lynn Kieffer, Chief Officer of Enanta Pharmaceuticals ENTA, has filed 0 purchases and 4 sales on the open market. Over the past 12 months that comes to a net sale of $30K. The latest trade was on 02/12.

TK

TK

Tara Lynn Kieffer

Chief Product Strategy Officer

Company

Enanta Pharmaceuticals ENTA

First filing

23/02/15

Trades

20 trades

Buys / sales

0 / 4

12-month net buying

−$30K

Last trade

02/12

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Enanta PharmaceuticalsENTA	Open-market sale	25/12/05	25/12/05	2,106 sh	$14.23	$29,968.38	−6.4%
Enanta PharmaceuticalsENTA	Open-market sale10b5-1 plan	24/12/06	24/12/10	2,283 sh	$8.06	$18,400.98	−7.2%
Enanta PharmaceuticalsENTA	Open-market sale10b5-1 plan	24/06/17	24/06/17	7,266 sh	$12.33	$89,589.78	−18.3%
Enanta PharmaceuticalsENTA	Open-market sale	23/12/05	23/12/06	2,125 sh	$9.63	$20,463.75	−5.4%